Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Toulouse Tech Transfer (TTT) is a French Technology Transfer Accelerator (SATT) that serves as a bridge between public research and the industrial market in the Occitanie region. The company specializes in the maturation of innovative technologies originating from academic laboratories, providing funding for proof-of-concept, intellectual property protection, and market validation. In the life sciences sector, TTT manages a diverse portfolio of projects spanning oncology, infectious diseases, neurology, and medical devices. By de-risking early-stage innovations, TTT facilitates their commercialization through licensing agreements with established pharmaceutical companies or the creation of high-growth biotech startups. TTT is supported by major institutional shareholders including Bpifrance and the University of Toulouse, ensuring a robust pipeline of academic-derived innovations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Toulouse Tech Transfer.